We are live on ! Find out more
TRIL

Trillium Therapeutics Inc.
TRIL

Delisted

TRIL was delisted on the 16th of November, 2021.

2 hedge funds and large institutions have $18K invested in Trillium Therapeutics Inc. in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 177 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 1812 (-179)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 177

100% less funds holding in top 10

Funds holding in top 10: 50 (-5)

100% less capital invested

Capital invested by funds: $1.38B → $18K (-$1.38B)

Holders
2
Holders Change
-179
Holders Change %
-98.9%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
Reduced
Closed
177
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BPGAM
151
BTG Pactual Global Asset Management
Bermuda
-$176K -10,000 Closed
FIA
152
FNY Investment Advisers
New York
-$175K -10,000 Closed
ST
153
Sphinx Trading
Illinois
-$176K -10,000 Closed
WAM
154
Weiss Asset Management
Massachusetts
-$176K -10,000 Closed
SAM
155
Shell Asset Management
Netherlands
-$143K -8,134 Closed
AIP
156
Ameritas Investment Partners
Nebraska
-$135K -7,670 Closed
QT
157
Quantbot Technologies
New York
-$121K -6,900 Closed
Walleye Trading
158
Walleye Trading
New York
-$112K -6,400 Closed
CG
159
Cutler Group
California
-$86K -4,900 Closed
Wells Fargo
160
Wells Fargo
California
-$81K -4,620 Closed
FF
161
FourThought Financial
Florida
-$39K -2,267 Closed
PFGIA
162
Patriot Financial Group Insurance Agency
Massachusetts
-$35K -2,000 Closed
HI
163
Harbour Investments
Wisconsin
-$25K -1,430 Closed
UBS Group
164
UBS Group
Switzerland
-$24K -1,355 Closed
QCG
165
Quadrant Capital Group
Ohio
-$20K -1,131 Closed
SIS
166
Sound Income Strategies
Florida
-$18K -1,000 Closed
PCM
167
PenderFund Capital Management
British Columbia, Canada
-$16K -700 Closed
TWA
168
TCI Wealth Advisors
Arizona
-$9K -508 Closed
Rockefeller Capital Management
169
Rockefeller Capital Management
New York
-$6K -382 Closed
TCWM
170
Total Clarity Wealth Management
Illinois
-$4K -250 Closed
SMG
171
Spectrum Management Group
Indiana
-$4K -200 Closed
LC
172
Lindbrook Capital
California
-$3K -144 Closed
PWM
173
Prentice Wealth Management
New York
-$2K -120 Closed
BAM
174
Bellevue Asset Management
Washington
-$2K -111 Closed
CAPTRUST Financial Advisors
175
CAPTRUST Financial Advisors
North Carolina
-$1K -34 Closed

TRIL Hedge Fund Activity: Q4 2021 in Review

2 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Trillium Therapeutics Inc. (TRIL) for Q4 2021, worth a combined $18K — down 100% from $1.38B a quarter earlier.

Sellers outnumbered buyers: 177 funds closed out of TRIL and 1 opened new positions — a net loss of 176 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $107M sold.

  • 2 institutional investors held Trillium Therapeutics Inc. (TRIL) as of Q4 2021, down from 181 in Q3 2021.
  • Funds reported $18K of Trillium Therapeutics Inc. stock for Q4 2021, down 100% quarter-over-quarter.
  • 1 fund opened new Trillium Therapeutics Inc. positions in Q4 2021 and 177 closed out, a net change of -176 holders.
  • The largest Trillium Therapeutics Inc. seller in Q4 2021 was BlackRock, an estimated $107M sold.

Based on aggregated 13F filings for Q4 2021.